Dialog Devices

At Dialog Devices, we develop innovative optical technologies to help meet the overwhelming demand for better healthcare.

Through advances in opto-electronics, we can now use natural light to 'see' below the surface of the skin.
Our technology is revolutionising the way medical conditions are diagnosed and monitored; improving the health and well-being of people around the world.

Patent awarded in China - Dialog Devices on 25th January 2012 have been granted patent no. CN101404929 for a peripheral arterial pate...

North West England to host trials of new products to boost long-term healthcare - A team at Royal Liverpool and Broadgreen University...

September is peripheral arterial disease awareness month! - Peripheral arterial disease also known as PAD; is a common, yet serious...

Dialog Devices receives European CE Mark Approval for Padd® for peripheral arterial disease assessment and obtains ISO Certification of ...

For rapid, non-invasive assessment of Peripheral Arterial Disease, to prevent heart disease and stroke

Find Out More »

Peripheral Arterial Disease (PAD) affects around 8-10 million people in US alone. People who experience symptoms of PAD have a 15 times greater risk of dying from cardiovascular disease, including heart attack and stroke, and a 1 in 4 chance of dying within 2 years. Many of these deaths are preventable if PAD is diagnosed earlier.

Find Out More »